These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 17566573

  • 1. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine?
    Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Poniatowski B, Pawlak K, Dobrzycki S.
    Int J Cardiol; 2008 Jul 04; 127(2):290-1. PubMed ID: 17566573
    [Abstract] [Full Text] [Related]

  • 2. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
    Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Pawlak K, Mysliwiec M, Lawnicki S, Szmitkowski M, Dobrzycki S.
    Kidney Blood Press Res; 2007 Jul 04; 30(6):408-15. PubMed ID: 17901710
    [Abstract] [Full Text] [Related]

  • 3. Plasma neutrophil-gelatinase-associated lipocalin and cystatin C could early diagnose contrast-induced acute kidney injury in patients with renal insufficiency undergoing an elective percutaneous coronary intervention.
    Liu XL, Wang ZJ, Yang Q, Yu M, Shen H, Nie B, Han HY, Gao F, Zhou YJ.
    Chin Med J (Engl); 2012 Mar 04; 125(6):1051-6. PubMed ID: 22613530
    [Abstract] [Full Text] [Related]

  • 4. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H.
    Scand J Clin Lab Invest; 2014 Mar 04; 74(2):81-8. PubMed ID: 24304491
    [Abstract] [Full Text] [Related]

  • 5. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention.
    Padhy M, Kaushik S, Girish MP, Mohapatra S, Shah S, Koner BC.
    Clin Chim Acta; 2014 Aug 05; 435():48-52. PubMed ID: 24804935
    [Abstract] [Full Text] [Related]

  • 6. Neutrophil-gelatinase-associated lipocalin and renal function after percutaneous coronary interventions.
    Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S.
    Am J Nephrol; 2006 Aug 05; 26(3):287-92. PubMed ID: 16772710
    [Abstract] [Full Text] [Related]

  • 7. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
    Wang L, Pu X.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr 05; 42(4):301-4. PubMed ID: 24924456
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil gelatinase-associated lipocalin and cystatin C could predict renal outcome in patients undergoing kidney allograft transplantation: a prospective study.
    Lebkowska U, Malyszko J, Lebkowska A, Koc-Zorawska E, Lebkowski W, Malyszko JS, Kowalewski R, Gacko M.
    Transplant Proc; 2009 Apr 05; 41(1):154-7. PubMed ID: 19249501
    [Abstract] [Full Text] [Related]

  • 9. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease.
    Malyszko J, Bachorzewska-Gajewska H, Poniatowski B, Malyszko JS, Dobrzycki S.
    Ren Fail; 2009 Apr 05; 31(10):910-9. PubMed ID: 20030526
    [Abstract] [Full Text] [Related]

  • 10. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
    Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S.
    Adv Med Sci; 2009 Apr 05; 54(2):221-4. PubMed ID: 19875355
    [Abstract] [Full Text] [Related]

  • 11. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
    Malyszko J, Bachorzewska-Gajewska H, Malyszko JS, Pawlak K, Dobrzycki S.
    Nephrology (Carlton); 2008 Apr 05; 13(2):153-6. PubMed ID: 18275504
    [Abstract] [Full Text] [Related]

  • 12. Early diagnostic markers for contrast nephropathy in patients undergoing coronary angiography.
    Shaker OG, El-Shehaby A, El-Khatib M.
    Angiology; 2010 Nov 05; 61(8):731-6. PubMed ID: 20529972
    [Abstract] [Full Text] [Related]

  • 13. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May 05; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 14. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 May 05; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography.
    Filiopoulos V, Biblaki D, Vlassopoulos D.
    Ren Fail; 2014 Jul 05; 36(6):979-86. PubMed ID: 24673459
    [Abstract] [Full Text] [Related]

  • 16. Renal effects of coronary artery bypass graft surgery in diabetic and non-diabetic patients: a study with urinary neutrophil gelatinase-associated lipocalin and serum cystatin C.
    Arun O, Celik G, Oc B, Unlu A, Celik JB, Oc M, Duman A.
    Kidney Blood Press Res; 2015 Jul 05; 40(2):141-52. PubMed ID: 25832128
    [Abstract] [Full Text] [Related]

  • 17. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.
    Ren Fail; 2008 Jul 05; 30(6):625-8. PubMed ID: 18661413
    [Abstract] [Full Text] [Related]

  • 18. Midkine: a novel and early biomarker of contrast-induced acute kidney injury in patients undergoing percutaneous coronary interventions.
    Malyszko J, Bachorzewska-Gajewska H, Koc-Zorawska E, Malyszko JS, Kobus G, Dobrzycki S.
    Biomed Res Int; 2015 Jul 05; 2015():879509. PubMed ID: 25629054
    [Abstract] [Full Text] [Related]

  • 19. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk.
    McCullough PA, Williams FJ, Stivers DN, Cannon L, Dixon S, Alexander P, Runyan D, David S.
    Am J Nephrol; 2012 Jul 05; 35(6):509-14. PubMed ID: 22627273
    [Abstract] [Full Text] [Related]

  • 20. Renal function after percutaneous coronary interventions depending on the type of hydration.
    Jarocka IT, Bachórzewska-Gajewska H, Kobus G, Czaban S, Małyszko J, Dobrzycki S.
    Adv Med Sci; 2013 Jul 05; 58(2):369-75. PubMed ID: 24285128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.